Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness...
industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Apr 04, 2024 8:23am
Positive In Vivo Preclinical Alzheimer’s results
https://mailchi.mp/02da2462c4f8/inmeds-inm-901-demonstrates-favorable-pharmacological-and-behavioral-effects-in-in-vivo-preclinical-alzheimers-disease-studies?e=5815d309bc
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Jan 25, 2024 9:16am
Good update on Inmed
https://wallstreetwaves.com/inmed-pharmaceuticals-has-multiple-milestones-coming-up-in-2024-with-a-focus-on-three-conditions-with-an-unmet-need/
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Jul 27, 2023 5:10am
INM revenues have been exploding
https://mailchi.mp/550c403a5512/inmed-provides-update-on-baymedica-rare-cannabinoid-business?e=5815d309bc
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 11, 2023 9:58pm
Minor Cannabinoid Sales - Ray of Hope
https://youtu.be/lTC25Wcj04I
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on May 15, 2023 2:47pm
INM Q3 report
https://mailchi.mp/d9827ae25b92/inmed-reports-second-quarter-fiscal-2023-financial-results-and-provides-business-update-13895526?e=5815d309bc
(1)
•••
zardoz00
X
View Profile
View Bullboard History
Post by
zardoz00
on Mar 13, 2023 8:56am
INM publishes peer reviewed study
https://mailchi.mp/dc7a414475c6/inmed-announces-publication-of-peer-reviewed-study-showing-the-anti-inflammatory-potential-of-rare-cannabinoids-in-skin-conditions?e=5815d309bc
(28)
•••
kijiji
X
View Profile
View Bullboard History
Post by
kijiji
on Feb 20, 2023 1:16pm
InMed 2nd Quarter Fiscal 2023 Results business update
VANCOUVER - InMed Pharmaceuticals Inc. ('InMed' or the 'Company') (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and
...more
(30)
•••
Stevemin
X
View Profile
View Bullboard History
Comment by
Stevemin
on Dec 21, 2022 4:54pm
RE:Where are all of the Adams fanboys?
I haven't posted here in a while because theres no need. No one wanted to hear the truth. Yet I am replying to a message i sent back in early April. Everything i said was true (except Adams hasnt
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Dec 02, 2022 2:03pm
BIDEN SIGNS CANNABIS BILL
https://www.marijuanamoment.net/biden-signs-marijuana-research-bill-a-historic-first-for-federal-cannabis-reform/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Nov 16, 2022 9:50pm
Chuck Schumer - Research Act
The Senate passed the Medical Marijuana and Cannabidiol Research Expansion Act that passed the House this year Itd help eliminate red tape hindering cannabis research for new treatments Now it goes to
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 16, 2022 3:40pm
INM ..... All that Volume & Price Action for what ?
I'll tell ya....... Its a fair trade...... your paper money for their paper ; ) Look at the positive ...... their paper is "marketable" What a game ! Next support is ~ $3.60 ish
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 16, 2022 11:40am
INM ..... early a.m runner now in PB mode
Broke support at $4.22 Just might be done No position
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 13, 2022 11:05pm
Radicle Science THCV study
Radicle study due out this month. https://www.prnewswire.com/news-releases/named-by-kpmg-as-one-of-americas-top-10-tech-innovators-radicle-science-bridges-proof-gap-for-health--wellness-industry
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Oct 05, 2022 9:09pm
RE:Curaleaf Buys Tryke
Erratum - correction. Not Tryke, Trokie. https://investors.inmedpharma.com/news-releases/news-release-details/inmed-supply-rare-cannabinoids-radicle-sciences-radicle-energy/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Oct 05, 2022 9:06pm
Curaleaf Buys Tryke
The largest Cannabis company in the world with ~1.5B in annual revenue just bought Tryke. InMed is supplying Tryke with THCV for the Radicle Science study. Might be a light at the end of the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer